Clinical Trial Update: Determination of Absorption and Elimination of Lamotrigine-XR [Phase 1, Phase 2]

View source ↗

Summary

This update reports a Phase 1/2 pharmacokinetic assessment of Lamotrigine-XR to determine its absorption and elimination. Results have been posted following com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Epilepsy

Drugs mentioned

• Lamotrigine-XR (lamotrigine)

Snippet

Sponsor: University of Minnesota | Conditions: Epilepsy, Seizures | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-01-20